Connect Biopharma Holdings
CNTB
25 hedge funds and large institutions have $16.4M invested in Connect Biopharma Holdings in 2022 Q3 according to their latest regulatory filings, with 6 funds opening new positions, 3 increasing their positions, 12 reducing their positions, and 10 closing their positions.
26% more capital invested
Capital invested by funds: $13M → $16.4M (+$3.4M)
4.05% less ownership
Funds ownership: 27.18% → 23.14% (-4%)
14% less funds holding
Funds holding: 29 → 25 (-4)
40% less first-time investments, than exits
New positions opened: 6 | Existing positions closed: 10
75% less repeat investments, than reductions
Existing positions increased: 3 | Existing positions reduced: 12
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
OCA
Octagon Capital Advisors
New York
|
+$541K |
| 2 |
CL
CSS LLC
Chicago,
Illinois
|
+$22.5K |
| 3 |
Renaissance Technologies
New York
|
+$19.7K |
| 4 |
JP Morgan Chase
New York
|
+$3.39K |
| 5 |
SA
SRH Advisors
Salina,
Kansas
|
+$1.44K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Janus Henderson Group
London,
United Kingdom
|
-$637K |
| 2 |
IC
Ikarian Capital
Dallas,
Texas
|
-$551K |
| 3 |
Adage Capital Partners
Boston,
Massachusetts
|
-$481K |
| 4 |
Citadel Advisors
Miami,
Florida
|
-$357K |
| 5 |
DCM
DAFNA Capital Management
Los Angeles,
California
|
-$218K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
26
Two Sigma Investments
New York
| – | -$24K | -28,016 | Closed |
|
|
CPIG
27
Chicago Partners Investment Group
Chicago,
Illinois
| – | -$17K | -20,651 | Closed |
|
|
VIA
28
Vident Investment Advisory
Alpharetta,
Georgia
| – | -$16K | -18,062 | Closed |
|
|
VF
29
Virtu Financial
New York
| – | -$14K | -16,658 | Closed |
|
30
D.E. Shaw & Co
New York
| – | -$12K | -13,750 | Closed |
|
31
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
| – | -$11K | -13,110 | Closed |
|
32
Wells Fargo
San Francisco,
California
| – | -$1K | -1,000 | Closed |
|
33
Bank of America
Charlotte,
North Carolina
| – | -$491 | -409 | -81% |
|
34
Fidelity Investments
Boston,
Massachusetts
| – | -$117 | -97 | -53% |
|
35
Royal Bank of Canada
Toronto,
Ontario, Canada
| – | +$183 | +152 | New |
|
CNTB Hedge Fund Activity: Q3 2022 in Review
25 of the 5,805 institutional investors tracked by Wall St. Rank reported a position in Connect Biopharma Holdings (CNTB) for Q3 2022, worth a combined $16.4M — up 26% from $13M a quarter earlier.
Sellers outnumbered buyers: 10 funds closed out of CNTB and 6 opened new positions — a net loss of 4 holders — while 12 trimmed existing stakes and 3 added.
The largest buyer was Octagon Capital Advisors, opening a new position worth an estimated $541K. The largest seller was Janus Henderson Group, exiting entirely with an estimated $637K sold.
- 25 institutional investors held Connect Biopharma Holdings (CNTB) as of Q3 2022, down from 29 in Q2 2022.
- Funds reported $16.4M of Connect Biopharma Holdings stock for Q3 2022, up 26% quarter-over-quarter.
- 6 funds opened new Connect Biopharma Holdings positions in Q3 2022 and 10 closed out, a net change of -4 holders.
- The largest Connect Biopharma Holdings buyer in Q3 2022 was Octagon Capital Advisors, an estimated $541K added.
- The largest Connect Biopharma Holdings seller in Q3 2022 was Janus Henderson Group, an estimated $637K sold.
Based on aggregated 13F filings for Q3 2022.